FindTrial
Sign In

Cancer Services during COVID-19 Pandemic â?? Importance of a symptoms based screening strategy

Continuation of Cancer Services in a prospective cohort during COVID-19 Pandemic â?? Policy implications of a symptoms based screening strategy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/11/028859
Enrollment
400
Registered
2020-11-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

All India Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a) All COVID -19 seronegative cancer patients who are planned for active chemotherapy and or radiotherapy during the next 60 days at Department of Medical Oncology IRCH / NCI and/or Department of Radiotherapy at NCI.

Exclusion criteria

Exclusion criteria: a) Patients who are seropositive at baseline or have a history of COVID-19 related symptoms over last 14 days of date of recruitment. b) Patients who have a history of recovery from documented COVID-19 infection in past.

Design outcomes

Primary

MeasureTime frame
Proportion of asymptomatic patients with successful completion of cancer directed therapy during the study periodTimepoint: 6 weeks—

Secondary

MeasureTime frame
noneTimepoint: none—

Countries

India

Contacts

Public ContactAkash Kumar

All India Institute of Medical Sciences

akashja08@yahoo.com91-9910850134

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026